Clinical Research Directory

Mi-RNA and COVID-19

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), induces a spectrum of clinical conditions ranging from asymptomatic infection to life threatening severe disease, characterized by respiratory failure, shock and multi-organ dysfunction requiring admission in the intensive care unit (ICU). The aim of the present study is to analyze miRNAs associated with SARS-CoV-2 infection, disease severity and mortality.

Official title: Circulating Mi-RNA Associated With Disease Severity and Outcome in COVID-19 Patients

Key Details

Conditions

Interventions

Locations (1)